S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
Log in

NYSEAMERICAN:ELMD - Electromed Stock Price, Forecast & News

$11.24
-0.04 (-0.35 %)
(As of 03/31/2020 04:00 PM ET)
Today's Range
$10.80
Now: $11.24
$11.52
50-Day Range N/A
52-Week Range
$4.75
Now: $11.24
$13.60
Volume65,051 shs
Average Volume99,140 shs
Market Capitalization$95.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Read More
Electromed logo

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:ELMD
Previous SymbolNYSEMKT:ELMD
CUSIPN/A
Phone+1-952-7589299

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees132
Market Cap$95.29 million
Next Earnings Date5/5/2020 (Estimated)
OptionableNot Optionable

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.


Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Electromed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Electromed.

When is Electromed's next earnings date?

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Electromed.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) posted its quarterly earnings results on Tuesday, February, 11th. The medical equipment provider reported $0.14 EPS for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.10. The medical equipment provider earned $8.55 million during the quarter. View Electromed's earnings history.

What price target have analysts set for ELMD?

1 analysts have issued 12-month price targets for Electromed's stock. Their forecasts range from $12.00 to $12.00. On average, they expect Electromed's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price. View analysts' price targets for Electromed.

Has Electromed been receiving favorable news coverage?

News articles about ELMD stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Electromed earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutElectromed.

Are investors shorting Electromed?

Electromed saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 49,300 shares, an increase of 142.9% from the February 27th total of 20,300 shares. Based on an average daily trading volume, of 78,400 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.7% of the company's shares are sold short. View Electromed's Current Options Chain.

Who are some of Electromed's key competitors?

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include NovaBay Pharmaceuticals (NBY), TransEnterix (TRXC), Rigel Pharmaceuticals (RIGL), Gilead Sciences (GILD), Novavax (NVAX), TherapeuticsMD (TXMD), AbbVie (ABBV), Agenus (AGEN), Akari Therapeutics (AKTX) and Athersys (ATHX).

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)
  • Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George J.D., Sec. (Age 70)
  • Ms. Kathryn Thompson, VP of Reimbursement

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $11.24.

How big of a company is Electromed?

Electromed has a market capitalization of $95.29 million. Electromed employs 132 workers across the globe. View additional information about Electromed.

What is Electromed's official website?

The official website for Electromed is http://smartvest.com/.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.


MarketBeat Community Rating for Electromed (NYSEAMERICAN ELMD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  176 (Thanks for Voting!)
Underperform Votes:  211 (Thanks for Voting!)
Total Votes:  387
MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe ELMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel